✦ LIBER ✦

A randomized phase III study of irinotecan and cisplatin (CP) versus etoposide and cisplatin (EP) in extensive-disease small-cell lung cancer (ED-SCLC): Japan Clinical Oncology Group Study (JCOG 9511)

✍ Scribed by Negoro, S; Noda, K; Nishiwaki, Y; Kawahara, M; Tamura, T; Sugiura, T; Yokayama, A; Mori, K; Fukuoka, M; Yoshimura, K; Saijo, N

Book ID: 118569640
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 112 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80095-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etoposide-cisplatin (EP) versus four-dru

Etoposide-cisplatin (EP) versus four-drug combination etoposide-cisplatin-epirubicin-cyclophosphamide (PCDE) in extensive disease small cell lung cancer (ED-SCLC). A FNCLCC phase III multicentre study

✍ Pujol, J; Daures, J; Riviere, A; Quoix, E; Depierre, A; Breton, J.L; Lemarie, E; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Phase III Study Comparing Amrubicin Plus

Phase III Study Comparing Amrubicin Plus Cisplatin With Irinotecan Plus Cisplatin in the Treatment of Extensive-Disease Small-Cell Lung Cancer: JCOG 0509

✍ Satouchi, M.; Kotani, Y.; Shibata, T.; Ando, M.; Nakagawa, K.; Yamamoto, N.; Ich 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 146 KB

Common arm comparative outcomes analysis

Common arm comparative outcomes analysis of phase 3 trials of cisplatin + irinotecan versus cisplatin + etoposide in extensive stage small cell lung cancer : Final patient-level results from Japan Clinical Oncology Group 9511 and Southwest Oncology Group 0124

✍ Primo N. Lara Jr; Kari Chansky; Taro Shibata; Haruhiko Fukuda; Tomohide Tamura; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

A phase III trial of etoposide and cispl

A phase III trial of etoposide and cisplatin in extensive small cell lung cancer: A cancer and Leukemia Group B study

✍ Mitchell, Edith P.; Perry, Michael C.; Luikart, Sharon D.; Cirrincione, Constanc 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 629 KB

Randomized phase II study of docetaxel p

Randomized phase II study of docetaxel plus cisplatin versus docetaxel plus irinotecan in advanced non-small-cell lung cancer. A West Japan Thoracic Oncology Group Study

✍ Saito, H; Yamamoto, N; Negoro, S; Nakagawa, K; Matsui, K; Kawahara, M; Takada, Y 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Phase I/II trial of cisplatin (CDDP), et

Phase I/II trial of cisplatin (CDDP), etoposide (ETP), and irinotecan (CPT-11) for the treatment of advanced non-small-cell lung cancer (NSCLC). Japan Clinical Oncology Group (JCOG) study 9512

✍ Makino, M; Tsukada, H; Yokoyama, A; Kurita, Y; Isobe, H; Watanabe, K; Saijo, N 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 129 KB